Clinical Trial

Sphenopalatine Ganglion Block and Cold Induced Headaches

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 31, 2025 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this study is to determine if a sphenopalatine ganglion (SPG) block, performed through intranasal atomization of 4% lidocaine, is able to prevent cold induced cephalgia ("Brain Freeze"). Secondary objectives will be to determine the degree of decreased pain/duration of brain freeze after sphenopalatine ganglion block
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-12; most recent amendment 2025-01-28.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-01-28
Trial Details
NCT Number NCT06310200
Lead Sponsor Wright State University
Conditions Cold Induced Headache, Brain Freeze, Cold Induced Cephalgia, Headache
Enrollment 30 participants
Start Date 2025-01-01
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-31